Citation Impact
Citing Papers
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Postmenopausal osteoporosis: patient choices and outcomes
1995
Child abuse: Adolescent records vs. adult recall
1990 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Osteoporosis
2006
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
The assessment of vertebral deformity: A method for use in population studies and clinical trials
1993
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
1990
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Design of the Fracture Intervention Trial
1993
Nondestructive determination of iliac crest cancellous bone strength by pQCT
1997
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Recent developments in vitamin D deficiency and muscle weakness among elderly people
2005
Cushing's syndrome
2015 Standout
Preventing fractures in elderly people
2003
Vitamin D Deficiency
2007 Standout
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1992
Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells
2005
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures
1995
Intravenous pamidronate treatment in osteogenesis imperfecta
1997
Osteoporosis: now and the future
2011 Standout
Bone histomorphometry in hypoparathyroid patients treated with vitamin D
1996
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy
1993
Treatment of Postmenopausal Osteoporosis
1998
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
1999
Skeletal remodeling in health and disease
2007 Standout
Treatment of postmenopausal osteoporosis
2002
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Biomedical applications of bisphosphonates
2013
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
1992
A tense situation: forcing tumour progression
2009 Standout
Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age
1998
Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes
1995
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression
1996 StandoutNobel
A review of postgastrectomy bone disease
1992
Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites
2004 StandoutNobel
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
2004 Standout
Management of patients on chronic glucocorticoid therapy: an endocrine perspective
2003
Suppression of bone formation by osteoclastic expression of semaphorin 4D
2011 Standout
The interleukin‐1 genotype as a severity factor in adult periodontal disease
1997 Standout
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
2002 StandoutNature
Periodontal diseases
2005 Standout
Production and Actions of Estrogens
2002 Standout
Magnesium Deficiency in Alcoholism: Possible Contribution to Osteoporosis and Cardiovascular Disease in Alcoholics
1994
Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone
2001
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Ghrelin: Structure and Function
2005 Standout
Prevention of falls and consequent injuries in elderly people
2005 Standout
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
1996
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Theoretical perspective: A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates
1996
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
1996
The control of the false discovery rate in multiple testing under dependency
2001 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Prevention of Nonvertebral Fractures by Alendronate
1997
Noninvasive assessment of bone mineral and structure: State of the art
1996
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
2009 Standout
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
2004 Standout
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
2005
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1996
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Vitamin D
1999
Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models
1991
Hypophosphatemia and Hyperphosphatemia
1991
Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib
2000
Effect of Calcitriol on Bone Loss After Cardiac or Lung Transplantation
2000
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
1995
Bone metabolism and disease in chronic kidney disease
2003
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
1995
Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog Vertebra
2003
Bisphosphonates: Mechanisms of Action
1998
Creatine and Creatinine Metabolism
2000 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of T. Storm being referenced
Severe hypophosphataemia during recovery from acute respiratory acidosis.
1984
Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosis
1994
Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
1990
The effects of short-term, high-dose treatment with prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D3 in monocytes from normal human subjects
1988
Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial
1993
Bone Disorder in Men with Chronic Alcoholism: A Reversible Disease?
1991
Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: A double-blind study on the high-dose, long-term effects of prednisone versus deflazacort
1992
Effect of a short course of 1,25-Dihydroxyvitamin D3 on biochemical markers of bone remodeling in adult male volunteers
1991
Effect of different doses of nasal salmon calcitonin on bone mass
1991
Glucocorticoid-Induced Osteoporosis in the Lumbar Spine, Forearm, and Mandible of Nephrotic Patients: A Double-Blind Study on the High-Dose, Long-Term Effects of Prednisone Versus Deflazacort
1993
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women postmenopausal osteoporosis
1991
Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis
1993
Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment
1985
Effect of β1‐adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal man
1987
LOW SERUM LEVELS OF 25-HYDROXYVITAMIN D AND 1,25-DIHYDROXYVITAMIN D IN INSTITUTIONALIZED OLD PEOPLE: INFLUENCE OF SOLAR EXPOSURE AND VITAMIN D SUPPLEMENTATION
1987